CMMI Evaluation Digest December 2021

 

 

December 2021 This newsletter highlights recently released Centers for Medicare & Medicaid Services (CMS) Center for Medicare and Medicaid Innovation  (Innovation Center) evaluation reports and publications. You can access reports by going to the data and reports page of the Innovation Center website. Reports highlighted in this edition: Independence at Home (IAH) Demonstration Oncology Care Model (OCM)

 

Independence at Home (IAH) Demonstration  Year Six Evaluation Report - Key Takeaways: Results of the evaluation of the demonstration’s first six years provide no compelling evidence that the payment incentive affected the delivery of care in a way that measurably reduced total Medicare expenditures or hospital use. Many IAH practices did not meet standards for all six quality measures tied to payment, even though doing so would have increased the amount of their incentive payments. The Two Page Overview: Findings-At-A-Glance (PDF) The Report (includes Overall Key Takeaways): Year Six Evaluation Report (PDF) Go directly to the Overall Key Takeaways (PDF) Additional Supporting Materials: Appendices (PDF) - Methods and supplemental tables Model Page: Independence At Home (IAH) Demonstration CMS.gov: www.cms.gov

 

Oncology Care Model (OCM) Performance Periods 1-6: OCM Impact on Payments Report - Key Takeaways: During performance period 1 (PP1) through PP6, OCM significantly reduced total episode payments (TEP) by about 1 percent. OCM led to relative reductions in payment for non-chemotherapy Part B drugs often used for supportive care, especially for higher-risk cancer episodes. OCM had no impact on Part B chemotherapy or Part D drug spending—the largest contributors to TEP—suggesting a limited ability of OCM practices to influence oncologists' cancer treatment decisions. When model payments from PP1-5 are included (monthly enhanced oncology services and performance-based payments), OCM resulted in net losses for Medicare. Case studies reveal that OCM led to more person-centered care, data-driven quality initiatives, and greater attention to the use of high-value supportive care drugs. OCM-led care delivery improvements benefited every patient, not only those with Medicare. The Two Page Overview: Findings-At-A-Glance (PDF) The Report (includes an Executive Summary): Performance Periods 1-6: OCM Impact on Payments Report (PDF) Go directly to the Executive Summary (PDF) Additional Supporting Materials: Participant Perspectives (PDF) - Participants’ reasons for joining OCM and what they learned Model Page: Oncology Care Model (OCM)

 

The CMS Innovation Center maintains a portfolio supporting the development and testing of innovative health care payment and service delivery models. It performs evaluations of these models and makes the results available to the public. Bringing you the latest CMS Innovation Center Evaluation Results: Watch out for future issues of our Evaluation Digest,  check out the CMS Innovation Center website, and follow us on Twitter.